Atkins Susan E.
Director
Award
Calculated transaction value
$0
17,000 shares @ $0
Traded
Aug 12, 2026
Filed
Aug 14, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
BioXcel Therapeutics
BTAI
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
9 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Atkins Susan E. Director | Aug 14, 2026 2-day lag | Award Aug 12, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Steinhart Richard I Chief Financial Officer | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Yocca Frank Chief Scientific Officer | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Mehta Vimal CEO And President | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | Not reported Reported range | SEC Form 4 View filing | |
| Rodriguez Javier See Remarks | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Mehta Vimal CEO And President | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Yocca Frank Chief Scientific Officer | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Steinhart Richard I Chief Financial Officer | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Rodriguez Javier See Remarks | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | Not reported Reported range | SEC Form 4 View filing |
Steinhart Richard I
Chief Financial Officer
Exercise
Reported value range
Not reported
35 shares
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Yocca Frank
Chief Scientific Officer
Exercise
Reported value range
Not reported
35 shares
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Mehta Vimal
CEO And President
Exercise
Reported value range
Not reported
219 shares
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Rodriguez Javier
See Remarks
Exercise
Calculated transaction value
$0
35 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Mehta Vimal
CEO And President
Exercise
Calculated transaction value
$0
219 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Yocca Frank
Chief Scientific Officer
Exercise
Calculated transaction value
$0
35 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Steinhart Richard I
Chief Financial Officer
Exercise
Calculated transaction value
$0
35 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Rodriguez Javier
See Remarks
Exercise
Reported value range
Not reported
35 shares
Traded
Jun 15, 2026
Filed
Jun 17, 2026